Genes and disease? It's what you do with what you have

The importance of gene regulation for common human disease

Genes and disease? It's what you do with what you have

snps_300.jpg
Associations of SNPs of the phase II HapMap with expression of the gene SGPP2 on chromosome 2. Shown are four-population multipopulation analysis and individual population analysis for CEU, CHB, JPT and YRI. Blue arrows represent the location (not to scale) and direction of transcription of <em>SGPP2</em>. In this case, the SNP was not rare in any of the populations (0.08 < MAF < 0.44), but the effect was small (R2 = 0.25, slope = 0.25); therefore, it was detected only in the larger sample obtained when the populations were pooled.

A new study published in Nature Genetics on Sunday 16 September 2007 show that common, complex diseases are more likely to be due to genetic variation in regions that control activity of genes, rather than in the regions that specify the protein code.

This surprising result comes from a study at the Wellcome Trust Sanger Institute of the activity of almost 14,000 genes in 270 DNA samples collected for the HapMap Project. The authors looked at 2.2 million DNA sequence variants (SNPs) to determine which affected gene activity.

They found that activity of more than 1300 genes was affected by DNA sequence changes in regions predicted to be involved in regulating gene activity, which often lie close to, but outside, the protein-coding regions.

"We predict that variants in regulatory regions make a greater contribution to complex disease than do variants that affect protein sequence. This is the first study on this scale and these results are confirming our intuition about the nature of natural variation in complex traits."

"One of the challenges of large-scale studies that link a DNA variant to a disease is to determine how the variant causes the disease: our analysis will help to develop that understanding, a vital step on the path from genetics to improvements in healthcare."

Dr Manolis Dermitzakis, senior author from the Wellcome Trust Sanger Institute

Past studies of rare, monogenic disease, such as cystic fibrosis and sickle-cell anaemia, have focused on changes to the protein-coding regions of genes because they have been visible to the tools of human genetics. With the HapMap and large-scale research methods, researchers can inspect the role of regions that regulate activity of many thousands of genes.

The HapMap Project established cell cultures from participants from four populations as well as, for some samples, information from families, which can help to understand inheritance of genetic variation. The team used these resources to study gene activity in the cell cultures and tie that to DNA sequence variation.

"We have generated an information resource readily available to investigators working in the mapping of variants underlying complex traits. Regions of association can be correlated with signatures of regulatory regions affecting gene expression."

Dr Panos Deloukas, Senior Investigator at the Wellcome Trust Sanger Institute

"We found strong evidence that SNP variation close to genes - where most regulatory regions lie - could have a dramatic effect on gene activity. Although many effects were shared among all four HapMap populations, we have also shown that a significant number were restricted to one population."

Dr Barbara Stranger, Postdoctoral fellow at the Wellcome Trust Sanger Institute

They also showed that genes required for the basic functions of the cell - so-called housekeeping genes - were less likely to be subject to genetic variation.

"This was exactly as we would expect: you can't mess too much with the fundamental life processes and we predicted we would find reduced effects on these genes."

Dr Manolis Dermitzakis, Sanger Institute

The study also detected SNP variants that affect the activity of genes located a great distance away. Genetic regulation in the human genome is complex and highly variable: a tool to detect such distant effects will expand the search for causative variants. The authors note, however, that the small sample size of 270 HapMap individuals is sensitive enough to detect only the strongest effects.

The results of this study are becoming available in public databases such as Ensembl for researchers to use.

The paper is accompanied by two others examining effects of changes to regulatory DNA in samples from asthma and from heart study patients.

Notes to Editors
Publications
  • Population genomics of human gene expression.

    Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP et al.

    Nature genetics 2007;39;10;1217-24

Funding

Funding was provided by the Wellcome Trust, the US National Institutes of Health, ENDGAME, Cancer Research UK and the Medical Research Council.

Participating Centres
  • The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton UK
  • Department of Oncology, University of Cambridge, Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge UK
  • European Bioinformatics Institute, Hinxton, UK
  • Computer Science Department, Stanford University, Stanford, California, USA
Selected Websites
Contact the Press Office

Emily Mobley, Media Manager

Tel +44 (0)1223 496 851

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Dr Matthew Midgley, Media Officer

Tel +44 (0)1223 494 856

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7748 379849

Recent News

Jumping genes can cause rare developmental disorders in children
Diagnoses achieved for three more children in the Deciphering Developmental Disorders project
First cell map of developing human liver reveals how blood and immune systems develop
Resource improves understanding of normal development and will support efforts to tackle diseases, such as leukaemia, that can form during early life
Fresh insights could lead to new treatments for liver disease
The fight against liver disease could be helped by the discovery of cells that cause liver scarring